SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103. A total of 127 filers reported holding SYNAGEVA BIOPHARMA CORP in Q4 2014. The put-call ratio across all filers is 1.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $359,000 | +18.1% | 3,677 | -16.8% | 0.01% | +20.0% |
| Q3 2014 | $304,000 | -74.6% | 4,420 | -61.3% | 0.01% | -72.2% |
| Q2 2014 | $1,196,000 | +213.9% | 11,411 | +148.6% | 0.02% | +200.0% |
| Q1 2014 | $381,000 | +114.0% | 4,590 | +66.5% | 0.01% | +100.0% |
| Q4 2013 | $178,000 | -62.0% | 2,757 | -62.7% | 0.00% | -66.7% |
| Q3 2013 | $468,000 | – | 7,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|